Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Subscribe to see Kytopen Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kytopen Corp. is a biotech, life sciences & techbio company headquartered in United States. It has raised at least $57.1M across the 7 funding rounds on record, 6 of them with a disclosed amount. Its most recent funding round, Seed, closed in April 2026. Xcout tracks 18 named people at Kytopen Corp., including Michael Chiu (CEO, President and Treasurer).
12 more named people on record for Kytopen Corp., with roles, board committees and tenure — see the full roster →
At least $57.1M raised across the 7 rounds on record (6 with a disclosed amount). The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 3 named | |
| SEC Form D filing | $7.1M | — | |
| SEC Form D filing | $5.7M | — | |
| Seed | $32.5M | 3 named | |
| SEC Form D filing | $3.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.